Drug Database
Back to search

Netherlands· NL-26f41c8dc3c1

Azacitidine Mylan 25 mg/ml, poeder voor suspensie voor injectie

A azacitidine product containing azacitidine, registered in Netherlands by Mylan Pharmaceuticals Limited. The same ATC class is registered in 18 of our 19 countries.

ATC L01BC07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAzacitidine Mylan 25 mg/ml, poeder vo…ATCL01BC07REGISTER NO.NL-26f41c8dc3c1PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about azacitidineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Azacitidine is registered in 18 of 19 countries.

Countries holding a registration under ATC L01BC07 (azacitidine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search azacitidine products by name

Azacitidine · ATC L01BC07

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of azacitidine costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.69 in France to $470.17 in Switzerland — a ×683 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Azacitidine · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$470.17
  • CZ Czechia$4.72
  • FR France$0.69
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AZACITIDINE
Manufacturer
Mylan Pharmaceuticals Limited
Country
Netherlands (NL)
ATC code
L01BC07
ATC class
Azacitidine
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/20/1426

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

75 interactions on record for azacitidine.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check azacitidine against other medicinesHow interaction checks work

Azacitidine · interactions on record

75 records

  • 30 severe
  • 45 moderate

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Azacitidine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All azacitidine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Azacitidin Hikma, Azacitidin Sandoz
  • Belgium · Azacitidin Sandoz, Azacitidine Eugia
  • Bulgaria · Азацитидин, Азацитидин Ромфарм
  • Cyprus · Azacitidine Koanaa 25 Mg/Ml, Azacitidine Sandoz
  • Czechia · Azacitidin Sandoz, Azacitidine Rompharm
  • Germany · Azacitidin, Azacitidin Aqvida
  • Denmark · Azacitidin "stada Arzneimittel Ag", Azacitidin Adalvo
  • Estonia · Azacitidine Auxilia
  • Spain · Azacitidina Dr. Reddys, Azacitidina Eugia
  • Finland · Azacitidine Hikma, Azacitidine Sandoz
  • France · Azacitidine Arrow, Azacitidine Biogaran
  • United Kingdom (Northern Ireland) · Azacitidine Amarox, Azacitidine Eugia (Uk)
  • Greece · Azacitidine Sandoz, Azacitidine Stada
  • Croatia · Azacitidin Pharmascience, Azacitidin Sandoz
  • Hungary · Azacitidin Aliud, Azacitidin Sandoz
  • Ireland · Azacitdine Clonmel, Azacitidine Clonmel
  • Iceland · Azacitidine Accord, Azacitidine Glenmark
  • Italy · Azacitidina Aurobindo, Azacitidina Eg Stada
  • Liechtenstein · Azacitidine Accord, Azacitidine Kabi
  • Lithuania · Azacitidine Auxilia, Azacitidine Icg Farma
  • Luxembourg · Azacitidine Azacitidine Eg 25 Mg/Ml Poudre Pour Suspension Injectable, Azacitidine Eurogenerics
  • Malta · Azacitidine Adalvo, Azacitidine Lotus
  • Norway · Azacitidin Sun, Azacitidin Tillomed
  • Poland · Azacitidine Eugia, Azacitidine Msn
  • Portugal · Azacitidina Eugia, Azacitidina Hikma
  • Romania · Azacitidină Aqvida, Azacitidină Dr. Reddy’s
  • Sweden · Azacitidine Azacitidine Lotus Pharma, Azacitidine Hikma
  • Slovenia · Azacitidin Sandoz, Azacitidin Stada
  • Slovakia · Azacitidine Glenmark, Azacitidine Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1c26b09-ec22-4dc2-ba5e-6237000ba011
GET /v1/drugs/c1c26b09-ec22-4dc2-ba5e-6237000ba011?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor suspensie voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/azacitidine-mylan-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Azacitidine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp124646",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "AZACITIDINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/03/27",
  "procedure_number": "EMEA/H/C/004984",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1426",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about azacitidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console